SCHEMBL6479256

SCHEMBL6479256

NC(=O)c1ccc(Oc2ccc(C[C@@H](CO)NC[C@H](O)c3cccc(Cl)c3)cc2)nc1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 15/20 0.61
ADRB1 P08588 10/20 0.61
ADRB2 P07550 9/20 0.53
SLC2A1 P11166 1/20 0.52
CYP2D6 P10635 2/20 0.49
ADRA1D P25100 1/20 0.49
ADRA1A P35348 1/20 0.49
ADRA1B P35368 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
GLA P06280 1/20 0.49
OPRM1 P35372 2/20 0.48
OPRD1 P41143 2/20 0.48
OPRK1 P41145 2/20 0.48
CYP3A4 P08684 1/20 0.48
HIF1A Q16665 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6480835 1.00 ADRB3 (0.61) ADRB3ADRB1ADRB2SLC2A1CYP2D6
Hydrochloric Acid SCHEMBL6480583 0.99 ADRB3 (0.61) ADRB3ADRB1ADRB2SLC2A1CYP2D6
Hydrochloric Acid SCHEMBL6480588 0.99 ADRB3 (0.61) ADRB3ADRB1ADRB2SLC2A1CYP2D6
Hydrochloric Acid SCHEMBL6488290 0.91 ADRB3 (0.71) ADRB3ADRB1ADRB2SLC2A1CYP2D6
Hydrochloric Acid SCHEMBL6488285 0.91 ADRB3 (0.71) ADRB3ADRB1ADRB2SLC2A1CYP2D6
SCHEMBL6479562 0.91 ADRB3 (0.61) ADRB3ADRB1ADRB2SLC2A1CYP2D6
SCHEMBL6479579 0.91 ADRB3 (0.61) ADRB3ADRB1ADRB2SLC2A1CYP2D6
Hydrochloric Acid SCHEMBL6479555 0.90 ADRB3 (0.60) ADRB3ADRB1ADRB2SLC2A1CYP2D6
Oxalic Acid SCHEMBL6479546 0.87 ADRB3 (0.58) ADRB3ADRB1ADRB2SLC2A1CYP2D6
Hydrochloric Acid SCHEMBL6479347 0.87 ADRB3 (0.48) ADRB3ADRB1ADRB2OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043358-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-02-24 US disclosed
US-20020143034-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2002-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020143034-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists ADRB1, ADRB2, ADRB3 ADRB3 3/4885ADRB1 1/4885ADRB2 2/4885
US-20050043358-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists ADRB2, ADRB1, ADRB3 ADRB3 3/4885ADRB1 2/4885ADRB2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.